Federal health subsidies cut off for gender transition coverage
H.R. 2202 — End Taxpayer Funding of Gender Experimentation Act of 2025 · Filed by Doug LaMalfa (R-CA) · 23 cosponsors · Introduced Mar 18, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits federal funds from paying for gender transition procedures and bars health insurance plans that cover such procedures from receiving federal subsidies under the Affordable Care Act. It defines gender transition procedures broadly to include hormonal treatments, surgeries, and cosmetic procedures, with narrow exceptions for intersex conditions and emergency medical care. States and individuals may still purchase separate coverage with non-federal money, but federal tax credits and employer health insurance subsidies cannot support plans that include gender transition coverage.
Why we flagged it
The bill's operative mechanism is to exclude a category of medical procedures from federal healthcare funding and subsidies. While framed as a taxpayer-protection measure, its primary effect is to restrict healthcare access for a specific population by removing federal financial support.
What the text implies
- The definition of 'gender transition procedure' is extraordinarily broad, capturing cosmetic surgeries (liposuction, hair reconstruction, facial feminization/masculinization) that may be sought for reasons unrelated to gender identity, potentially affecting coverage for non-transgender patients.
- Section 306 carves out treatment of 'complications' from gender transition procedures, but the bill does not define what constitutes a complication or establish a mechanism for determining causation, creating potential litigation and coverage disputes.
- The intersex exception (Section 307(3)(B)(i)-(ii)) requires 'medically verifiable disorder of sex development' diagnosed through 'genetic or biochemical testing,' but does not specify which tests qualify, potentially excluding individuals with clinical but non-genetic intersex conditions.
- By disqualifying plans from ACA subsidies and employer credits, the bill may incentivize insurers to drop gender transition coverage entirely rather than offer separate plans, reducing market options even for those paying out-of-pocket.
- The definition of 'sex' in Section 307(5) as 'biologically determined' and the definitions of 'male' and 'female' tied to reproductive capacity may conflict with existing state law, federal civil rights law, and Social Security Administration sex designation rules, creating legal uncertainty.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill restricts access to federally-subsidized health coverage for a specific medical procedure, reducing healthcare options for individuals who would otherwise qualify for ACA subsidies or employer health insurance credits. While non-federal alternatives remain available, the removal of federal financial support creates a concrete barrier to care for lower-income individuals who depend on federal subsidies.
Named in the bill
Internal Revenue Service, Centers for Medicare & Medicaid Services, Department of Health and Human Services, Health insurance issuers, Employers offering health insurance, States administering Medicaid
Where it stands
23 cosponsors: 23 Republicans.
- Mar 18, 2025 — Introduced · Congress.gov: “Introduced in House”
- Mar 18, 2025 — Referred to House Committee on Ways and Means and House Committee on the Judiciary · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $439,908 in lobbying spend. A filing names 132 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Doug LaMalfa, the sponsor, reported $279,010 in PAC receipts in the 2026 cycle.
- Human Rights Campaign — $439,908 on 2 filings
Lobbying Disclosure Act filings through Jul 17, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (12,633 characters) on Sep 28, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 17, 2026 · page rendered 2026-10-20.
“Federal health subsidies cut off for gender transition coverage” QuorumCivic. https://share.quorumcivic.app/bill/119/hr2202 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.